Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021
The British Journal of Psychiatry · 2026-01 · 228 (1) · 18-28
DOI: 10.1192/bjp.2024.267 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 22.01.2025. Verfasst von Wei Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Anxiety Disorders, Depressive Disorder, Cost of Illness, COVID-19. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Depressive and anxiety disorders constitute a major component of the disease burden of mental disorders in China.
Aims
To comprehensively evaluate the disease burden of depressive and anxiety disorders in China.
Method
The raw data is sourced from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021. This study presented the disease burden by prevalence and disability-adjusted life years (DALYs) of depressive and anxiety disorders at both the national and provincial levels in China from 1990 to 2021, and by gender (referred to as 'sex' in the GBD 2021) and age.
Results
From 1990 to 2021, the number of depressive disorder cases (from 34.4 to 53.1 million) and anxiety disorders (from 40.5 to 53.1 million) increased by 54% (95% uncertainty intervals: 43.9, 65.3) and 31.2% (19.9, 43.8), respectively. The age-standardised prevalence rate of depressive disorders decreased by 6.4% (2.9, 10.4), from 3071.8 to 2875.7 per 100 000 persons, while the prevalence of anxiety disorders remained stable. COVID-19 had a significant adverse impact on both conditions. There was considerable variability in the disease burden across genders, age groups, provinces and temporal trends. DALYs showed similar patterns.
Conclusion
The burden of depressive and anxiety disorders in China has been rising over the past three decades, with a larger increase during COVID-19. There is notable variability in disease burden across genders, age groups and provinces, which are important factors for the government and policymakers when developing intervention strategies. Additionally, the government and health authorities should consider the potential impact of public health emergencies on the burden of depressive and anxiety disorders in future efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Harbin Medical University, Harbin, China.
- School of Public Health, Zunyi Medical University, Zunyi, China.
- Department of Cell Biology, School of Basic Medicine, Harbin Medical University, Harbin, China.
- The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
- Department of Chronic Non-Communicable Diseases, Guizhou Centre for Disease Control and Prevention, Guiyang, China.
- Institute for Hospital Management of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Wei Tian
Zitieren
APA
Tian, W., Yan, G., Xiong, S., Zhang, J., Peng, J., Zhang, X., Zhou, Y., Liu, T., Zhang, Y., Ye, P., Zhao, W., & Tian, M. (2026). Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry, 228(1), 18-28. https://doi.org/10.1192/bjp.2024.267
Vancouver
Tian W, Yan G, Xiong S, Zhang J, Peng J, Zhang X, et al. Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry. 2026;228(1):18-28. doi:10.1192/bjp.2024.267
BibTeX
@article{Tian2026,
author = {Tian, Wei and Yan, Guangcan and Xiong, Shangzhi and Zhang, Jing and Peng, Junyi and Zhang, Xinyi and Zhou, Yuanzhong and Liu, Tao and Zhang, Yafeng and Ye, Pengpeng and Zhao, Wenran and Tian, Maoyi},
title = {Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021},
journal = {The British Journal of Psychiatry},
year = {2026},
volume = {228},
number = {1},
pages = {18--28},
doi = {10.1192/bjp.2024.267}
}
EUVIMED